Moreover, BP1 reduces the binding affinity of FGF-2 for HSPGs [14–16] and by this BP1 can amplify the angiogenic activity of FGF-2 in the KS tumor environment. The gene discussed is FGF2; the disease is Kaposi's sarcoma.